View the study questions and tabulations of top-level results for each question in the topline for this NORC Spotlight on Health
Tang H, Lu Y, Okun MS, Donahoo WT, Ramirez-Zamora A, Wang F, Huang Y, Armstrong M, Svensson M, Virnig BA, DeKosky ST, Bian J, Guo J (2024) Glucagon-like Peptide-1 receptor agonists and risk of Parkinsons Disease in patients with type 2 diabetes: a Population-based Cohort Study
Molecules 27 (13)
Qu trnh ny khin cho da tng to ra cc sc t Melanin sng v ngn chn hc t hnh thnh
Developed to treat symptoms of type 2 diabetes, Ozempic (semaglutide) was licensed for medical use in 2017 by Novo Nordisk
However, this needs to be verified by further clinical trials